The Use of Cyproheptadine in Pediatric Feeding Disorders

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 30, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Pediatric Feeding Disorder, ChronicAvoidant Restrictive Food Intake Disorder
Interventions
DRUG

Cyproheptadine

Initiation of Cyproheptadine at 0.25mg/kg once daily by mouth at bedtime and titration up to at most three times daily as per participant's primary gastroenterologist.

BEHAVIORAL

Nutritional Counseling

This includes in person counseling by a provider once in office for up to 15 minutes as well as standardized hand out with basic nutritional guidance on high-calorie foods.

BEHAVIORAL

Behavioral Counseling

This includes in person counseling by a provider once in office for up to 15 minutes as well as standardized hand out with basic behavioral guidance.

Trial Locations (1)

30345

RECRUITING

University of Miami Department of Pediatric Gastroenterology, Miami

All Listed Sponsors
lead

University of Miami

OTHER

NCT06751290 - The Use of Cyproheptadine in Pediatric Feeding Disorders | Biotech Hunter | Biotech Hunter